Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06649383
Recruiting Phase 4

Virtual Reality (VR) Could Be a Good Alternative to Relaxing or Pain-relieving Medication

NCT06649383 · tracked via the Priya Life Science Sweden tracker
Sponsor
Pether Jildenstal
Phase
Phase 4
Started
2024-12-16
Last updated
2025-01-13

Condition(s) studied

Virtual RealityDistractionElderly (people Aged 65 or More)

Investigational drug(s) / intervention(s)

Virtual reality

Virtual reality: Participant will try virtual reality glasses with tailormade software films to see if it's possible to use them as distraction during awake surgery. We will measure doses of propofol given, level of anxiety, experience of the patient and surgeons satisfaction.

Study summary

We want to investigate whether Virtual Reality (VR) could be a good alternative to the relaxing or pain-relieving medications that are often used to alleviate anxiety when patients undergo surgery under local anesthesia.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * over 65 years, planed surgery in local anesthesia/regional anesthesia Exclusion Criteria: * dementia, unable to cooperate, cognitive impairment

Primary outcome measure(s)

  • propofol mg/kg — during the surgery (90 minutes max)
    dose of propofol given during surgery to the participant

Trial sites (2)

FacilityCityRegionStatus
Alingsås lasarett Alingsås Västra Götaland County Recruiting
Sahlgrenska universitetssjukhuset Gothenburg Västra Götaland County Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06649383 on ClinicalTrials.gov ↗ ← All trials in Sweden